Akebia Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 53.5M | 57.6M | 58.8M | 62.5M | 57.3M | 46.5M | 37.4M | 43.6M |
| Cost of Goods Sold | 12.6M | 12.2M | 9.7M | 9.9M | 7.6M | 20.4M | 14.2M | 8.3M |
| Gross Profit | 40.9M | 45.4M | 49.1M | 52.6M | 49.7M | 26.1M | 23.3M | 35.4M |
| R&D Expenses | 14.8M | 26.6M | 14.6M | 11.0M | 9.8M | 11.8M | 8.5M | 7.6M |
| Operating Expenses | 45.6M | 54.0M | 44.6M | 38.5M | 36.2M | 40.4M | 35.8M | 44.1M |
| Operating Income | -4.7M | -8.6M | 4.4M | 14.1M | 13.5M | -14.3M | -12.5M | -8.7M |
| Other Income / Gains | -4.2M | -2.7M | -3.3M | -13.8M | -7.4M | -8.5M | -7.5M | 143K |
| Net Income | -9.1M | -12.2M | 540K | 247K | 6.1M | -22.8M | -20.0M | -8.6M |
| EPS (Diluted) | -0.034 | -0.046 | 0.002 | 0.001 | 0.026 | -0.10 | -0.095 | -0.04 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.764 | 0.788 | 0.835 | 0.841 | 0.867 | 0.562 | 0.622 | 0.81 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 23.1M | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 4.6M | 0 | 0 |
| Selling General And Administrative Expenses | 30.4M | 26.1M | 30.0M | 26.6M | 25.7M | 27.7M | 26.5M | 0 |
| Other Expenses | 379K | 1.2M | 0 | 896K | 701K | 978K | 769K | 36.4M |
| Cost And Expenses | 58.2M | 66.2M | 54.3M | 48.4M | 43.8M | 60.8M | 49.9M | 52.4M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | -4.7M | 4.8M | 4.7M | 6.8M | 7.8M | 6.9M | 6.7M | 2.1M |
| Depreciation And Amortization | 328K | 321K | 318K | 316K | 314K | 9.3M | 9.4M | 9.4M |
| Ebitda | -13.3M | -6.1M | 6.2M | 7.4M | 14.2M | -6.6M | -4.0M | 1.2M |
| Ebitdaratio | -0.248 | -0.106 | 0.106 | 0.118 | 0.248 | -0.142 | -0.107 | 0.027 |
| Operating Income Ratio | -0.088 | -0.148 | 0.076 | 0.226 | 0.236 | -0.308 | -0.334 | -0.20 |
| Income Before Tax | -8.9M | -11.2M | 1.2M | 247K | 6.1M | -22.8M | -20.0M | -8.6M |
| Income Before Tax Ratio | -0.167 | -0.195 | 0.02 | 0.004 | 0.107 | -0.49 | -0.535 | -0.197 |
| Income Tax Expense | 126K | 1.0M | 615K | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -0.169 | -0.212 | 0.009 | 0.004 | 0.107 | -0.49 | -0.535 | -0.197 |
| Epsdiluted | -0.034 | -0.046 | 0.002 | 0.001 | 0.025 | -0.10 | -0.095 | -0.04 |
| Weighted Average Shs Out | 267.0M | 265.4M | 264.8M | 262.6M | 235.5M | 218.7M | 210.3M | 209.7M |
| Weighted Average Shs Out Dil | 267.0M | 265.4M | 274.4M | 271.1M | 241.6M | 218.7M | 210.3M | 209.7M |